About Lippon Pharma Private Limited
Data last updated:
Lippon Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2019PTC129735. Its GSTIN is 33AADCL9477E1ZC (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Ramalingam and Komala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No:211 Cdn Nagar Main Road Nerkundram, Chennai, Tamil Nadu, India – 600107.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.82 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹31.77 Lakh (net margin 3.6%) and EBITDA of ₹55.02 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 127% over five years.
The company is associated with 1 brand: Lippon.
For more details, the company can be reached via its website lipponpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo:211 Cdn Nagar Main Road Nerkundram, Chennai, Tamil Nadu, India – 600107
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lippon Pharma Private Limited
The main business activity of Lippon Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lippon Pharma Private Limited FY 2024 filings available
Lippon Pharma Private Limited reported revenue of ₹8.82 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lippon Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 127% over five years, including 36% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lippon Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹55.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31.77 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lippon Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lippon Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lippon Pharma Private Limited
Lippon Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akin Laboratories Pvt Ltd | ₹8.84 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
| Colorchem Industries Limited | ₹8.84 Cr (FY 2023) | •••• | •••• | -14.0% | •••• | Indore, Madhya Pradesh, India |
| Ruby Organics Private Limited | ₹8.83 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Lef Chem Private Limited | ₹8.83 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Uttar Pradesh, India |
| Pinnacle Chlorochem Private Limited | ₹8.82 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Kalol, Gujarat, India |
| Lippon Pharma Private Limited this company | ₹8.82 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Chennai, Tamil Nadu, India |
| Metal Tech Paints & Chemicals Private Limited | ₹8.81 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Rewari, Haryana, India |
| Krishidhaan Biocare Private Limited | ₹8.81 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Indore, Madhya Pradesh, India |
| Globalpine Products (OPC) Private Limited | ₹8.81 Cr (FY 2024) | •••• | •••• | 188.0% | •••• | Barabanki, Uttar Pradesh, India |
| Road Building International (India) Private Limited | ₹8.81 Cr (FY 2022) | •••• | •••• | -63.0% | •••• | Gurgaon, Haryana, India |
| Silicon Stamptech Private Limited | ₹8.81 Cr (FY 2025) | •••• | •••• | 1509.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Lippon Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lippon Pharma Private Limited
Lippon Pharma Private Limited is audited by CHARLES & CHANDRASEKAR for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHARLES & CHANDRASEKAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lippon Pharma Private Limited
Lippon Pharma has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramalingam | Director | 27 Nov 2023 | 2 Years 10 Months | Current |
| Komala | Director | 14 May 2021 | 5 Years 4 Months | Current |
| Nazerkhan Alfin | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
| Ramanathan Rajeshwari | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
| Venkatraman | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
| Kaliyaperumal Vadivel | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
Ownership and Shareholding of Lippon Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lippon Pharma Private Limited
Lippon Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Lippon Pharma Private Limited
Lippon Pharma operates one associated brand: Lippon. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines in India. | lipponpharma.com |
Employees and EPFO Compliance at Lippon Pharma Private Limited
Employment history and EPFO contributions of people linked to Lippon Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lippon Pharma Private Limited
Lippon Pharma Private Limited has 7 board changes on record since 2019: 6 appointments and 1 cessation. The latest: Ramalingam was appointed as Director on 27 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Lippon Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lippon Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lippon Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lippon Pharma Private Limited
Lippon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCL9477E1ZC | Tamil Nadu | Active | 20 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lippon Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lippon Pharma Private Limited
Lippon Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 June 2019 (7+ years old) and is registered under CIN U51909TN2019PTC129735.
Lippon Pharma reported revenue of ₹8.82 Cr for FY 2025 (up 36% YoY).
Lippon Pharma has 6 current directors:
- Ramalingam - Director
- Komala - Director
- Nazerkhan Alfin - Director
- Ramanathan Rajeshwari - Director
- Venkatraman - Director
- Kaliyaperumal Vadivel - Director
Lippon Pharma reported a net profit of ₹31.77 Lakh (net margin 3.6%) and EBITDA of ₹55.02 Lakh (EBITDA margin 6.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lippon Pharma is 43% over three years and 127% over five years. In the latest year (FY 2025) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lippon Pharma is 33AADCL9477E1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Lippon Pharma is U51909TN2019PTC129735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lippon Pharma was incorporated on 04 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Lippon Pharma by revenue are Akin Laboratories Pvt Ltd, Colorchem Industries Limited, Ruby Organics Private Limited, Lef Chem Private Limited, Pinnacle Chlorochem Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramalingam was appointed as Director on 27 Nov 2023. Priyadharisini ceased to be Director on 03 Nov 2023. Komala was appointed as Director on 14 May 2021. Lippon Pharma has 7 board changes on record in total.
Yes, Lippon Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).